Andrew Adler (Former)
1 – 5 of 7
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD
(
- Contribution to journal › Article
- 2022
-
Mark
A novel two-factor monosynaptic TRIO tracing method for assessment of circuit integration of hESC-derived dopamine transplants
(
- Contribution to journal › Article
-
Mark
Robust derivation of transplantable dopamine neurons from human pluripotent stem cells by timed retinoic acid delivery
(
- Contribution to journal › Article
- 2020
-
Mark
Transsynaptic tracing and its emerging use to assess graftreconstructed neural circuits
(
- Contribution to journal › Article
-
Mark
Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson’s disease
(
- Contribution to journal › Article